Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia

por Basu, Anirban, Benson, Carmela, Alphs, Larry
Publicado 2018

Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs

por Bossie, Cynthia A., Alphs, Larry D., Correll, Christoph U.
Publicado 2015

Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?

por Alphs, Larry, Benedetti, Fabrizio, Fleischhacker, W. Wolfgang, Kane, John M.
Publicado 2012

Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization

por Markowitz, Michael, Karve, Sudeep, Panish, Jessica, Candrilli, Sean D, Alphs, Larry
Publicado 2013

Treatment effect with paliperidone palmitate compared with oral antipsychotics in patients with recent‐onset versus more chronic schizophrenia and a history of criminal justice sys...

por Alphs, Larry, Bossie, Cynthia, Mao, Lian, Lee, Erin, Starr, H. Lynn
Publicado 2015

The Health-Related Quality of Life, Work Productivity, Healthcare Resource Utilization, and Economic Burden Associated with Levels of Suicidal Ideation Among Patients Self-Reportin...

por Benson, Carmela, Singer, David, Carpinella, Colleen M, Shawi, May, Alphs, Larry
Publicado 2021

Incidence and time course of extrapyramidal symptoms with oral and long-acting injectable paliperidone: a posthoc pooled analysis of seven randomized controlled studies

por Gopal, Srihari, Liu, Yanning, Alphs, Larry, Savitz, Adam, Nuamah, Isaac, Hough, David
Publicado 2013

Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder

por Bossie, Cynthia A., Turkoz, Ibrahim, Alphs, Larry, Mahalchick, Lucy, Fu, Dong-Jing
Publicado 2017

Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, dou...

por Alphs, Larry, Bossie, Cynthia A, Sliwa, Jennifer K, Ma, Yi-Wen, Turner, Norris
Publicado 2011

Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms

por Macfadden, Wayne, Adler, Caleb M, Turkoz, Ibrahim, Haskins, John T, Turner, Norris, Alphs, Larry
Publicado 2011

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia

por Sliwa, Jennifer Kern, Bossie, Cynthia A, Fu, Dong-Jing, Turkoz, Ibrahim, Alphs, Larry
Publicado 2012

Blinded Prospective Evaluation of Computer-Based Mechanistic Schizophrenia Disease Model for Predicting Drug Response

por Geerts, Hugo, Spiros, Athan, Roberts, Patrick, Twyman, Roy, Alphs, Larry, Grace, Anthony A.
Publicado 2012

Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies

por Markowitz, Michael, Fu, Dong-Jing, Levitan, Bennett, Gopal, Srihari, Turkoz, Ibrahim, Alphs, Larry
Publicado 2013

Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate

por Sliwa, Jennifer Kern, Fu, Dong-Jing, Bossie, Cynthia A, Turkoz, Ibrahim, Alphs, Larry
Publicado 2014

Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database

por Voss, Erica A., Ryan, Patrick B., Stang, Paul E., Hough, David, Alphs, Larry
Publicado 2015

Benefit–risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia

por Levitan, Bennett, Markowitz, Michael, Turkoz, Ibrahim, Fu, Dong-Jing, Gopal, Srihari, Alphs, Larry
Publicado 2016

An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression

por Wu, Bingcao, Cai, Qian, Sheehan, John J., Benson, Carmela, Connolly, Nancy, Alphs, Larry
Publicado 2019

Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial

por Bossie, Cynthia A, Sliwa, Jennifer K, Ma, Yi-Wen, Fu, Dong-Jing, Alphs, Larry
Publicado 2011

Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose

por Samtani, Mahesh N, Nuamah, Isaac, Gopal, Srihari, Remmerie, Bart, Kern Sliwa, Jennifer, Alphs, Larry
Publicado 2013

Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial

por Bossie, Cynthia A., Fu, Dong-Jing, Sliwa, Jennifer Kern, Alphs, Larry, Ma, Yi-Wen
Publicado 2011